Edward Chu

11.6k total citations · 1 hit paper
251 papers, 8.2k citations indexed

About

Edward Chu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edward Chu has authored 251 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Oncology, 96 papers in Molecular Biology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edward Chu's work include Colorectal Cancer Treatments and Studies (90 papers), Cancer Treatment and Pharmacology (45 papers) and Biochemical and Molecular Research (32 papers). Edward Chu is often cited by papers focused on Colorectal Cancer Treatments and Studies (90 papers), Cancer Treatment and Pharmacology (45 papers) and Biochemical and Molecular Research (32 papers). Edward Chu collaborates with scholars based in United States, China and Ukraine. Edward Chu's co-authors include Vincent T. DeVita, Carmen J. Allegra, James J. Lee, John C. Schmitz, Jan H. Beumer, J C Drake, Frank Maley, S Zinn, Jingfang Ju and Yael Schenker and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Edward Chu

244 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A History of Cancer Chemotherapy

2008 1.3k citations Vincent T. DeVita, Edward Chu Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward Chu United States	47	3.8k	3.5k	984	800	722	251	8.2k
Sharon Marsh United States	43	3.0k 0.8×	2.9k 0.9×	648 0.7×	708 0.9×	519 0.7×	109	6.7k
Jerry M. Collins United States	52	3.1k 0.8×	2.7k 0.8×	1.3k 1.3×	886 1.1×	637 0.9×	176	9.0k
Nathan A. Berger United States	58	4.3k 1.2×	5.2k 1.5×	730 0.7×	1.2k 1.5×	700 1.0×	244	11.6k
Peter Nygren Sweden	47	2.7k 0.7×	2.8k 0.8×	768 0.8×	885 1.1×	412 0.6×	234	7.0k
Giuseppe Toffoli Italy	46	3.1k 0.8×	3.9k 1.1×	922 0.9×	1.1k 1.4×	334 0.5×	337	8.8k
Lynn M. Schuchter United States	57	7.3k 1.9×	4.4k 1.3×	1.3k 1.3×	1.2k 1.5×	535 0.7×	208	11.6k
Denise J. Roe United States	50	2.3k 0.6×	2.7k 0.8×	890 0.9×	1.1k 1.3×	943 1.3×	241	10.6k
Alan V. Boddy United Kingdom	41	2.2k 0.6×	2.4k 0.7×	670 0.7×	465 0.6×	593 0.8×	188	5.9k
Alwin D. R. Huitema Netherlands	56	4.3k 1.1×	2.9k 0.8×	2.0k 2.0×	790 1.0×	1.1k 1.6×	552	12.9k
Aaron D. Schimmer Canada	62	3.0k 0.8×	7.0k 2.0×	636 0.6×	1.6k 2.0×	957 1.3×	320	11.5k

Countries citing papers authored by Edward Chu

Since Specialization

Citations

This map shows the geographic impact of Edward Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Chu more than expected).

Fields of papers citing papers by Edward Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Chu. The network helps show where Edward Chu may publish in the future.

Co-authorship network of co-authors of Edward Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Chu. A scholar is included among the top collaborators of Edward Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Chu. Edward Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krishnamurthy, Anuradha, Hong Wang, John C. Rhee, et al.. (2025). Phase I trial of ATR inhibitor elimusertib with FOLFIRI in advanced or metastatic gastrointestinal malignancies (ETCTN 10406). Cancer Chemotherapy and Pharmacology. 95(1). 27–27. 4 indexed citations

Chu, Edward, et al.. (2025). Understanding inequalities in spatial accessibility to multi-tier healthcare for older adults in rapidly aging Bangladesh. Journal of Transport & Health. 44. 102121–102121. 1 indexed citations

Cheng, En, et al.. (2025). Artificial Intelligence Chatbots and Their Responses to Most Searched Spanish Cancer Questions. Cancer Medicine. 14(21). e71364–e71364.

Gao, Chenxi, Shih–Fan Kuan, Chunhui Cai, et al.. (2024). FAK loss reduces BRAFV600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation. eLife. 13. 1 indexed citations

Bell, Sarah, Andrew D. Althouse, Robert M. Arnold, et al.. (2024). Associations of Health Care Utilization and Therapeutic Alliance in Patients with Advanced Cancer. Journal of Palliative Medicine. 27(4). 515–520.

Rosenzweig, Margaret, Andrew D. Althouse, Lindsay M. Sabik, et al.. (2021). The Association Between Area Deprivation Index and Patient-Reported Outcomes in Patients with Advanced Cancer. Health Equity. 5(1). 8–16. 63 indexed citations

Cohen, Michael S., Andrew D. Althouse, Robert M. Arnold, et al.. (2020). Does Advance Care Planning Actually Reduce Hope in Advanced Cancer? (TH322A). Journal of Pain and Symptom Management. 59(2). 417–418. 1 indexed citations

Gao, Chenxi, Guangming Chen, Wenhuo Hu, et al.. (2019). PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-CateninY654. Cellular and Molecular Gastroenterology and Hepatology. 8(4). 561–578. 10 indexed citations

Chu, Edward, et al.. (2015). Cost-Effectiveness of Adjuvant Chemotherapy in the Treatment of Early-Stage Colon Cancer. Clinical Colorectal Cancer. 14(4). 219–226. 4 indexed citations

10.

Appleman, Leonard J., Sanjeeve Balasubramaniam, Robert A. Parise, et al.. (2014). A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent. Clinical Cancer Research. 21(4). 721–729. 5 indexed citations

11.

Wei, Ning, Edward Chu, Peter Wipf, & John C. Schmitz. (2014). Protein Kinase D as a Potential Chemotherapeutic Target for Colorectal Cancer. Molecular Cancer Therapeutics. 13(5). 1130–1141. 54 indexed citations

12.

Schenker, Yael, Douglas B. White, Margaret Rosenzweig, et al.. (2014). Care Management by Oncology Nurses To Address Palliative Care Needs: A Pilot Trial To Assess Feasibility, Acceptability, and Perceived Effectiveness of the CONNECT Intervention. Journal of Palliative Medicine. 18(3). 232–240. 47 indexed citations

13.

Kudo, Kenji, Yaguang Xi, Yuan Wang, et al.. (2010). Translational control analysis by translationally active RNA capture/microarray analysis (TrIP–Chip). Nucleic Acids Research. 38(9). e104–e104. 19 indexed citations

14.

Anderson, Gerard F. & Edward Chu. (2007). Expanding Priorities — Confronting Chronic Disease in Countries with Low Income. New England Journal of Medicine. 356(3). 209–211. 135 indexed citations

15.

Liu, Shwu-Huey, Zaoli Jiang, Rajendra Marathe, et al.. (2006). PHY906 as a broad-spectrum enhancer in cancer therapy: Clinical and preclinical results in hepatocellular carcinoma. Cancer Research. 66. 506–506. 15 indexed citations

16.

Chu, Edward & Richard L. Edelson. (2006). Yale cancer center: Past, present, and future. The Yale Journal of Biology and Medicine. 79. 199–200. 1 indexed citations

17.

Chu, Edward & Vincent T. DeVita. (2003). Physician's cancer chemotherapy drug manual 2008. Medical Entomology and Zoology. 27(1). 189–90. 86 indexed citations

18.

Chu, Edward, Sitki Copur, Jingfang Ju, et al.. (1999). Thymidylate Synthase Protein and p53 mRNA Form an In Vivo Ribonucleoprotein Complex. Molecular and Cellular Biology. 19(2). 1582–1594. 80 indexed citations

19.

Chu, Edward, Donna Voeller, Kristen L. Jones, et al.. (1994). Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells. Molecular and Cellular Biology. 14(1). 207–213. 18 indexed citations

20.

Chu, Edward, et al.. (1959). The importance of early diagnosis of bronchogenic carcinoma: clinical analysis of 236 cases of bronchogenic cancer in the municipality of Shanghai.. PubMed. 79. 19–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact